Ethionamide-induced gynecomastia

J Pharmacol Pharmacother. 2012 Apr;3(2):196-9. doi: 10.4103/0976-500X.95532.

Abstract

Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.

Keywords: Antituberculosis therapy; drug-induced gynecomastia; ethionamide.

Publication types

  • Case Reports